Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list A newly published randomized clinical trial in JAMA Psychiatry evaluates whether mirtazapine, a widely used antidepressant, can reduce methamphetamine use…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Treatment-resistant depression (TRD) remains one of the most challenging conditions in psychiatry. Despite multiple pharmacologic and neuromodulatory options, remission rates…
March 2026: What Busy Clinicians Shouldn’t Miss March 2026 brought several important updates in psychopharmacology, along with a new book & course release and a meaningful discussions within our clinical community. Here’s a quick summary of key highlights.…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Psychedelic-assisted therapy (PAT) has been widely promoted as a breakthrough treatment for depression, often showing large effect sizes in early…
Let’s Do It Together
Subscribe To The Blog
Report
There was a problem reporting this post.
Block Member?
Please confirm you want to block this member.
You will no longer be able to:
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.